TCW Senior Loan ETF
SLNZ · ETF
About SLNZ
- Issuer
- TCW
- Expense ratio
- 0.65%
- Assets under management
- $225.90M
- Inception
- Nov 18, 2024
- Asset class
- Fixed Income
- Website
- tcw.com
SLNZ key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 2.00K
- Volume
- 93
- Open price
- $45.51
- High today
- $45.24
- Low today
- $45.24
- 52 Week high
- $47.10
- 52 Week low
- $44.58
TCW Senior Loan ETF (SLNZ) at a glance
TCW Senior Loan ETF (SLNZ) last traded at $45.24, with a price-to-earnings ratio of 0.00.
Volume so far is 93 shares, below the average of 2.00K shares a day.
Over the past year TCW Senior Loan ETF has ranged from $44.58 to $47.10, and now sits 26% of the way up that range.
SLNZ news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
TCW Significantly Expands ETF Offerings, Unveiling Five New Actively Managed Fixed Income ETFs
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.